Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00567567 · OUTCOME

Enumeration of Peripheral Blood Cluster of Differentiation (CD)3, CD4, and CD8 Cells

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
cells/mm^3
Interval / dispersion
Full Range
Time frame
Up to 6 months after completion of assigned myeloablation therapy

What was measured

A descriptive comparison of the median number of T-cells (CD3, CD4, CD8) between treatment arms (single vs. tandem myeloablative regimens) will be performed.

Analysis population: All eligible patients that had CD3, CD4 and CD8T-cell count evaluated at the end of reporting period 3.

Groups in this outcome

Single HST (CEM)

Induction therapy + single myeloablative consolidation

Tandem HST (CEM), Randomly Assigned

Induction therapy + tandem myeloablative consolidation

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Single HST (CEM)43
Tandem HST (CEM), Randomly Assigned43

Reported measurements

CD3

Analysis denominator · Participants

GroupSource count
Single HST (CEM)43
Tandem HST (CEM), Randomly Assigned42
Values in cells/mm^3 · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Single HST (CEM)200Not reported231549Not reported
Tandem HST (CEM), Randomly Assigned255.5Not reported132987Not reported
CD4

Analysis denominator · Participants

GroupSource count
Single HST (CEM)42
Tandem HST (CEM), Randomly Assigned43
Values in cells/mm^3 · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Single HST (CEM)73Not reported8626Not reported
Tandem HST (CEM), Randomly Assigned81Not reported41186Not reported
CD8

Analysis denominator · Participants

GroupSource count
Single HST (CEM)41
Tandem HST (CEM), Randomly Assigned43
Values in cells/mm^3 · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Single HST (CEM)104Not reported81170Not reported
Tandem HST (CEM), Randomly Assigned151Not reported42529Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        23
        upper Limit
        1549
        value
        200
      2. group Id
        OG001
        lower Limit
        13
        upper Limit
        2987
        value
        255.5
    denoms
    1. counts
      1. group Id
        OG000
        value
        43
      2. group Id
        OG001
        value
        42
      units
      Participants
    title
    CD3
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        8
        upper Limit
        626
        value
        73
      2. group Id
        OG001
        lower Limit
        4
        upper Limit
        1186
        value
        81
    denoms
    1. counts
      1. group Id
        OG000
        value
        42
      2. group Id
        OG001
        value
        43
      units
      Participants
    title
    CD4
  3. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        8
        upper Limit
        1170
        value
        104
      2. group Id
        OG001
        lower Limit
        4
        upper Limit
        2529
        value
        151
    denoms
    1. counts
      1. group Id
        OG000
        value
        41
      2. group Id
        OG001
        value
        43
      units
      Participants
    title
    CD8
denoms
  1. counts
    1. group Id
      OG000
      value
      43
    2. group Id
      OG001
      value
      43
    units
    Participants
description
A descriptive comparison of the median number of T-cells (CD3, CD4, CD8) between treatment arms (single vs. tandem myeloablative regimens) will be performed.
dispersion Type
Full Range
groups
  1. description
    Induction therapy + single myeloablative consolidation
    id
    OG000
    title
    Single HST (CEM)
  2. description
    Induction therapy + tandem myeloablative consolidation
    id
    OG001
    title
    Tandem HST (CEM), Randomly Assigned
param Type
MEDIAN
population Description
All eligible patients that had CD3, CD4 and CD8T-cell count evaluated at the end of reporting period 3.
reporting Status
POSTED
time Frame
Up to 6 months after completion of assigned myeloablation therapy
title
Enumeration of Peripheral Blood Cluster of Differentiation (CD)3, CD4, and CD8 Cells
type
SECONDARY
unit Of Measure
cells/mm^3

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice